MedTrace Logo

Habit Reversal Training for Children and Adolescents With Trichotillomania

NCT01445444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-03-10

No results posted yet for this study

Summary

The purpose of the current study is:

1. To evaluate the effectiveness of a habit reversal training (HRT) approach for children ages 7 to 17 years of age inclusive with a diagnosis of trichotillomania.
2. To explore factors that may relate to symptom severity, treatment outcome, and psychosocial impairment (e.g., specific symptom presence, co-morbidity, emotional regulation).

Conditions

  • Trichotillomania

Interventions

BEHAVIORAL

Habit Reversal Training

* 8 weekly therapy sessions lasting 50 minutes based on the protocol outlined by Woods (2001). * The overall focus of treatment is to provide patients with tools to help them manage and reduce hair-pulling. * components: * Session 1. (a) to develop an understanding of the subject's hair-pulling through an initial interview; and (b) to establish a protocol for ongoing assessment. * Session 2. implement habit reversal, including awareness training, competing response training, and social support. * Sessions 3-8. For subjects with a single hair-pulling site, Session 3 will review and practice HRT procedures and name solutions to problems that may have arisen. For those with multiple hair-pulling sites, treatment will be reviewed for the first site in the hierarchy.

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Adam B Lewin, Ph.D. · University of South Florida

  • Omar Rahman, Ph.D. · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-12-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01445444 on ClinicalTrials.gov